Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenette Skees

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Cancers|August 9, 2020
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced MelanomaNabanita Mukherjee, Carol M Amato, Jenette Skees, et al.
Cell Death & Disease|June 10, 2020
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cellsNabanita Mukherjee, Jenette Skees, Kaleb J Todd, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Cancers|August 9, 2020
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced MelanomaNabanita Mukherjee, Carol M Amato, Jenette Skees, et al.
Cell Death & Disease|June 10, 2020
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cellsNabanita Mukherjee, Jenette Skees, Kaleb J Todd, et al.
Pageof 1